Scientific and Medical Equipment House Company (4014.SR)
SAR 51.1
(0.2%)
SAR 51.1
(0.2%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 63.85 Million SAR | -45.12% |
| 2022 | 117.33 Million SAR | 68.69% |
| 2021 | 69.56 Million SAR | 238.87% |
| 2020 | -50.09 Million SAR | -19.54% |
| 2019 | -41.9 Million SAR | 8.87% |
| 2018 | -45.98 Million SAR | -24.81% |
| 2017 | -36.84 Million SAR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 18.96 Million SAR | -14.13% |
| 2024 Q1 | 22.2 Million SAR | -33.63% |
| 2023 Q3 | 12.02 Million SAR | -44.4% |
| 2023 FY | 64.4 Million SAR | -45.12% |
| 2023 Q4 | 33.45 Million SAR | 178.22% |
| 2023 Q1 | 18.57 Million SAR | -67.13% |
| 2023 Q2 | 21.62 Million SAR | 16.39% |
| 2022 Q4 | 56.52 Million SAR | 181.34% |
| 2022 FY | 117.33 Million SAR | 68.69% |
| 2022 Q2 | 24.64 Million SAR | 53.34% |
| 2022 Q1 | 16.07 Million SAR | -34.56% |
| 2022 Q3 | 20.09 Million SAR | -18.48% |
| 2021 Q2 | 16.42 Million SAR | 23.76% |
| 2021 Q1 | 13.26 Million SAR | -1.38% |
| 2021 FY | 69.56 Million SAR | 238.87% |
| 2021 Q4 | 24.56 Million SAR | 34.07% |
| 2021 Q3 | 18.32 Million SAR | 11.57% |
| 2020 Q2 | 14.89 Million SAR | -0.0% |
| 2020 Q1 | 14.89 Million SAR | 0.0% |
| 2020 FY | -50.09 Million SAR | -19.54% |
| 2020 Q4 | 13.45 Million SAR | 0.0% |
| 2020 Q3 | 13.45 Million SAR | -9.67% |
| 2019 FY | -41.9 Million SAR | 8.87% |
| 2018 FY | -45.98 Million SAR | -24.81% |
| 2017 FY | -36.84 Million SAR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|